Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
9 studies found for:    Open Studies | "Hereditary Breast and Ovarian Cancer Syndrome"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Hereditary Breast and Ovarian Cancer Syndrome"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Not yet recruiting Women at Risk of Breast Cancer and OLFM4
Condition: Hereditary Breast and Ovarian Cancer Syndrome
Intervention: Biological: OLFM4
2 Recruiting The Women Choosing Surgical Prevention (WISP) Trial
Condition: Hereditary Breast and Ovarian Cancer Syndrome
Interventions: Procedure: Salpingectomy;   Procedure: Oophorectomy;   Behavioral: Questionnaires
3 Recruiting Impact of a Psychoeducational Intervention on Expectations and Coping in Young Women Exposed to a High HBOC Risk
Condition: Hereditary Breast and Ovarian Cancer Syndrome
Intervention: Behavioral: psychoeducation
4 Not yet recruiting Neoadjuvant Carboplatin in Triple Negative Breast Cancer
Condition: BRCA1 Hereditary Breast and Ovarian Cancer Syndrome
Interventions: Drug: Doxorubicin;   Drug: Carboplatin;   Drug: Paclitaxel;   Drug: Cyclophosphamide
5 Recruiting Cancer Genetics Hereditary Cancer Panel Testing
Condition: Hereditary Breast and Ovarian Cancer
Interventions: Other: Questionnaires;   Other: Blood Draw and Baseline Questionnaire
6 Recruiting Efficacy of Lifestyle Intervention in BRCA1/2 Mutation Carriers
Condition: Hereditary Breast and Ovarian Cancer
Intervention: Behavioral: Structured exercise training plus mediterranean diet
7 Recruiting Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry
Conditions: Breast Cancer;   Hereditary Breast and Ovarian Cancer
Intervention:
8 Not yet recruiting Cost of Cancer Risk Management in Women at Elevated Genetic Risk for Ovarian Cancer Who Participated on GOG-0199
Conditions: Fallopian Tube Carcinoma;   Hereditary Breast and Ovarian Cancer Syndrome;   Ovarian Carcinoma;   Primary Peritoneal Carcinoma
Interventions: Procedure: Evaluation of Cancer Risk Factors;   Other: Medical Chart Review;   Other: Study of Socioeconomic and Demographic Variables
9 Recruiting A Phase II Single Arm Pilot Study of the Chk1/2 Inhibitor (LY2606368) in BRCA1/2 Mutation Associated Breast or Ovarian Cancer, Triple Negative Breast Cancer, High Grade Serous Ovarian Cancer, and Metastatic Castrate-Resistant Prostate Cancer
Conditions: Ovarian Cancer;   Breast Cancer;   Prostate Cancer
Intervention: Drug: LY2606368

Study has passed its completion date and status has not been verified in more than two years.